Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss
Yahoo
Monday, October 3, 2011 - 11:15am
tags:
Qnexa, obesity, Vivus
Biotech Calendar: Key Dates for October
TheStreet.com
Monday, October 3, 2011 - 11:13am
tags:
biotech, flurosorafenib, ONYX Pharmaceuticals, Bayer, Rigel, Teva Pharmaceuticals, Biogen Idec, BG-12, Heplisav, Amgen, Dynavax, Pacira, Bristol-Myers Squibb, Dapagliflozin, EXPAREL, cabozantinib, Exelixis
GlaxoSmithKline Looks for Bolt-On Buys in India
WSJ Online
Monday, October 3, 2011 - 11:07am
tags:
GSK, India
Why Universities Are Key to the Future of Biotech
Xconomy
Monday, October 3, 2011 - 11:04am
tags:
biotech
Insurer Won’t Pay For Avastin Breast Cancer Use
Pharmalot
Monday, October 3, 2011 - 11:03am
tags:
breast cancer, Avastin, insurance, Genentech
Early Stage Biotech Financing: Fewer, Leaner, and Better?
Forbes
Monday, October 3, 2011 - 10:42am
tags:
biotech, financing
5-Star Stocks Poised to Pop: Endo Pharmaceuticals
Motley Fool
Monday, October 3, 2011 - 10:41am
tags:
Endo
Sangamo Nerve Regrowth Drug Fails Key Test
TheStreet.com
Monday, October 3, 2011 - 10:40am
tags:
nerve regrowth, Sangamo BioSciences, SB-509, diabetic neuropathy
MedImmune In-Licenses Cancer Immunotherapy Tremelimumab from Pfizer
Yahoo
Monday, October 3, 2011 - 10:39am
tags:
MedImmune, cancer immunotherapy, Pfizer, tremelimumab, AstraZeneca, CTLA-4 monoclonal antibody
Teva Broadens Platform In Japan's Growing Generics Market
Seeking Alpha
Sunday, October 2, 2011 - 12:46pm
tags:
Teva Pharmaceuticals, Kowa, generics
China Biotech Week In Review: Sinovac Begins Foray Into Animal Health Vaccine
Seeking Alpha
Sunday, October 2, 2011 - 12:45pm
tags:
Sinovac, animal health, Cardinal Health, Sanjiu Medical and Pharmaceutical, Guangdong Zhongsheng Pharma, Takeda, Merck
Mergers: (EU) Commission approves acquisition of parts of Teva by Procter & Gamble
IEWY News
Sunday, October 2, 2011 - 12:42pm
tags:
Teva Pharmaceuticals, Proctor & Gamble, M&A
Onyx Pharma submits NDA for carfilzomib in relapsed and refractory multiple myeloma
Pharmabiz
Sunday, October 2, 2011 - 12:35pm
tags:
ONYX Pharmaceuticals, Carfilzomib, proteasome inhibitors, Multiple Myeloma
The Next Big Thing in Biotech: Hep C Drugs (video)
The Street
Sunday, October 2, 2011 - 12:31pm
tags:
hepatitis C, Vertex, Pharmasset, Idenix, Inhibitex
Sangamo's Phase II Results To Be Announced Monday - Expect Good News
Seeking Alpha
Sunday, October 2, 2011 - 12:28pm
tags:
Sangamo BioSciences, SB-509, diabetic neuropathy
Teva: Growth, Yield And Value All Wrapped In One Package
Seeking Alpha
Sunday, October 2, 2011 - 12:27pm
tags:
Teva Pharmaceuticals
Biogen, Teva, Other Drug Makers Face Stock Catalysts in October
Minyanville
Saturday, October 1, 2011 - 1:59pm
tags:
Biogen, Teva Pharmaceuticals, Novartis, Bristol-Myers Squibb, AstraZeneca, Alexion
We Don't Care if It's the First Lupus Drug in 50 Years (in UK)
Motley Fool
Saturday, October 1, 2011 - 1:57pm
tags:
lupus, Benlysta, Human Genome Sciences, GSK
A Drug Market That's 366 Million Strong
Motley Fool
Saturday, October 1, 2011 - 1:56pm
tags:
diabetes
Relief for Warner Chilcott
Yahoo/Zacks
Saturday, October 1, 2011 - 1:55pm
tags:
Warner Chilcott, Mylan, DORYX, patents

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.